By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



100 American Metro Boulevard
Suite 106
Hamilton  New Jersey  08619  U.S.A.
Phone: 609-528-9400 Fax: n/a


Medical Device

Company News
MedAvante VIRGILâ„¢ Investigative Study Platform Adopted By Drug Developers 10/2/2014 7:47:11 AM
MedAvante Introduces VIRGIL™ Investigative Study Platform 5/7/2014 9:30:16 AM
FDA Approves NDA Supported By MedAvante Central Ratings 7/31/2012 12:28:19 PM
Cipher Pharmaceuticals (DND.TO) Using MedAvante Centralized Ratings in Phase 3 Study 12/7/2010 10:00:58 AM
Rexahn Pharmaceuticals, Inc. to Use MedAvante Centralized Ratings in MDD Phase 2b Study 10/26/2010 11:33:51 AM
MedAvante Release: FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters 9/14/2010 11:15:48 AM
MedAvante Opens Moscow Office and Successfully Completes First Centralized Ratings Assessment 5/6/2010 11:32:37 AM
MedAvante to Deliver Remote, Expert Patient Assessment in $25 Million, Innovative NIMH Study of Early Schizophrenia Treatment 1/14/2010 8:29:44 AM
ICON and MedAvante Sign Alliance Agreement 3/16/2009 11:30:00 AM